78 related articles for article (PubMed ID: 34580726)
1. A retrospective analysis of azacitidine treatment for juvenile myelomonocytic leukemia.
Honda Y; Muramatsu H; Nanjo Y; Hirabayashi S; Meguro T; Yoshida N; Kakuda H; Ozono S; Wakamatsu M; Moritake H; Yasui M; Sano H; Manabe A; Sakashita K
Int J Hematol; 2022 Feb; 115(2):263-268. PubMed ID: 34714526
[TBL] [Abstract][Full Text] [Related]
2. Clinical and molecular features of
Yoshida T; Muramatsu H; Wakamatsu M; Sajiki D; Murakami N; Kitazawa H; Okamoto Y; Taniguchi R; Kataoka S; Narita A; Hama A; Okuno Y; Takahashi Y
Haematologica; 2023 Nov; 108(11):3115-3119. PubMed ID: 37226702
[No Abstract] [Full Text] [Related]
3. Layered immunity and layered leukemogenicity: Developmentally restricted mechanisms of pediatric leukemia initiation.
Mendoza-Castrejon J; Magee JA
Immunol Rev; 2023 May; 315(1):197-215. PubMed ID: 36588481
[TBL] [Abstract][Full Text] [Related]
4. Current and Emerging Technologies for the Analysis of the Genome-Wide and Locus-Specific DNA Methylation Patterns.
Tost J
Adv Exp Med Biol; 2022; 1389():395-469. PubMed ID: 36350519
[TBL] [Abstract][Full Text] [Related]
5. Genomic and Epigenomic Landscape of Juvenile Myelomonocytic Leukemia.
Fiñana C; Gómez-Molina N; Alonso-Moreno S; Belver L
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267643
[TBL] [Abstract][Full Text] [Related]
6. Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia.
Kitazawa H; Okuno Y; Muramatsu H; Aoki K; Murakami N; Wakamatsu M; Suzuki K; Narita K; Kataoka S; Ichikawa D; Hamada M; Taniguchi R; Kawashima N; Nishikawa E; Narita A; Nishio N; Hama A; Loh ML; Stieglitz E; Kojima S; Takahashi Y
Blood Adv; 2021 Dec; 5(24):5507-5518. PubMed ID: 34580726
[TBL] [Abstract][Full Text] [Related]
7. Clinical parameter-based prediction of DNA methylation classification generates a prediction model of prognosis in patients with juvenile myelomonocytic leukemia.
Imaizumi T; Meyer J; Wakamatsu M; Kitazawa H; Murakami N; Okuno Y; Yoshida T; Sajiki D; Hama A; Kojima S; Takahashi Y; Loh M; Stieglitz E; Muramatsu H
Sci Rep; 2022 Aug; 12(1):14753. PubMed ID: 36042365
[TBL] [Abstract][Full Text] [Related]
8. International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia.
Schönung M; Meyer J; Nöllke P; Olshen AB; Hartmann M; Murakami N; Wakamatsu M; Okuno Y; Plass C; Loh ML; Niemeyer CM; Muramatsu H; Flotho C; Stieglitz E; Lipka DB
Clin Cancer Res; 2021 Jan; 27(1):158-168. PubMed ID: 33139265
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia.
Stieglitz E; Mazor T; Olshen AB; Geng H; Gelston LC; Akutagawa J; Lipka DB; Plass C; Flotho C; Chehab FF; Braun BS; Costello JF; Loh ML
Nat Commun; 2017 Dec; 8(1):2127. PubMed ID: 29259179
[TBL] [Abstract][Full Text] [Related]
10. Juvenile myelomonocytic leukemia: who's the driver at the wheel?
Niemeyer CM; Flotho C
Blood; 2019 Mar; 133(10):1060-1070. PubMed ID: 30670449
[TBL] [Abstract][Full Text] [Related]
11. Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia.
Chang TY; Dvorak CC; Loh ML
Blood; 2014 Oct; 124(16):2487-97. PubMed ID: 25163700
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
